Loading...
Cognex Corp (CGNX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial performance and analysts have raised price targets, the recent price decline, insider selling, and lack of strong proprietary trading signals suggest waiting for a better entry point.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 57.399, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its key support level (S1: 55.313), with a recent price drop of -3.59% in regular trading and -0.38% in post-market trading.

Analysts have raised price targets significantly, with multiple buy ratings and targets as high as $
Hedge funds have increased their buying activity by 2450.31% over the last quarter.
The company reported strong Q4 financials with revenue up 9.86% YoY, net income up 15.23% YoY, and EPS up 18.75% YoY.
Insiders are selling heavily, with a 4627.11% increase in selling activity over the last month, including sales by key executives.
Gross margin dropped by -4.34% YoY in Q4
The stock has a 50% chance of declining -8.49% in the next month based on historical patterns.
In Q4 2025, Cognex reported revenue of $252.3M (up 9.86% YoY), net income of $32.66M (up 15.23% YoY), and EPS of $0.19 (up 18.75% YoY). However, gross margin dropped to 65.75%, down -4.34% YoY.
Analysts have raised price targets significantly, with the highest target at $75. Several firms, including TD Cowen, HSBC, and UBS, maintain buy ratings, citing strong Q4 results, operational efficiencies, and margin expansion. However, some analysts remain neutral due to valuation concerns.